PTPRC and neoplasm: Tumor cell populations were labeled with antibodies and analyzed by flow cytometry to identify leukocytes (CD45+/CD31−), endothelial cells (CD45−/CD31+) and tumor cells (CD45−/CD31−) (Figure S3).